SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ASP Isotopes Inc. of Class Action Lawsuit and Upcoming Deadlines - ASPI

NEW YORK, Dec. 9, 2024

The class action concerns whether ASPI and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

You have until February 3, 2025, to ask the Court to appoint you as Lead Plaintiff for the class if you are a shareholder who purchased or otherwise acquired ASPI securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.        

[Click here for information about joining the class action]  

On October 30, 2024, the Company announced it had entered into a term sheet with TerraPower, LLC "related to the construction of a uranium enrichment facility capable of producing High Assay Low-Enriched Uranium (HALEU) and the future supply of HALEU to TerraPower." 

Then, on November 26, 2024, Fuzzy Panda Research published a report alleging that the Company is "using old, disregarded laser enrichment technology to masquerade as a new, cutting-edge Uranium enrichment."  Citing interviews with experts, the report alleged that the Company's reported cost estimates and timeline for building its HALEU uranium facilities was misleading to the point of being "delusional."   The report further alleged the Company had significantly overstated the significance of its agreement with TerraPower, which was only a "non-binding" memorandum of understanding entered into to "put pressure on [TerraPower's] real suppliers."  The report also alleged that the Company's subsidiary, Quantum Leap Energy, appeared to be completely absent from its registered South African address.